• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解析受体结合能与中和 SARS-CoV-2 变异株的分子机制

Molecular insights into receptor binding energetics and neutralization of SARS-CoV-2 variants.

机构信息

Louvain Institute of Biomolecular Science and Technology, Université catholique de Louvain, Louvain-la-Neuve, Belgium.

Institute of Fundamental Technological Research, Polish Academy of Sciences, Pawińskiego 5B, 02-106, Warsaw, Poland.

出版信息

Nat Commun. 2021 Nov 30;12(1):6977. doi: 10.1038/s41467-021-27325-1.

DOI:10.1038/s41467-021-27325-1
PMID:34848718
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8633007/
Abstract

Despite an unprecedented global gain in knowledge since the emergence of SARS-CoV-2, almost all mechanistic knowledge related to the molecular and cellular details of viral replication, pathology and virulence has been generated using early prototypic isolates of SARS-CoV-2. Here, using atomic force microscopy and molecular dynamics, we investigated how these mutations quantitatively affected the kinetic, thermodynamic and structural properties of RBD-ACE2 complex formation. We observed for several variants of concern a significant increase in the RBD-ACE2 complex stability. While the N501Y and E484Q mutations are particularly important for the greater stability, the N501Y mutation is unlikely to significantly affect antibody neutralization. This work provides unprecedented atomistic detail on the binding of SARS-CoV-2 variants and provides insight into the impact of viral mutations on infection-induced immunity.

摘要

尽管自 SARS-CoV-2 出现以来,全球在知识方面取得了前所未有的进步,但几乎所有与病毒复制、病理学和毒力的分子和细胞细节相关的机制知识都是使用 SARS-CoV-2 的早期原型分离株生成的。在这里,我们使用原子力显微镜和分子动力学研究了这些突变如何定量影响 RBD-ACE2 复合物形成的动力学、热力学和结构特性。我们观察到几种关注的变体的 RBD-ACE2 复合物稳定性显著增加。虽然 N501Y 和 E484Q 突变对更高的稳定性特别重要,但 N501Y 突变不太可能显著影响抗体中和作用。这项工作提供了 SARS-CoV-2 变体结合的空前原子细节,并深入了解病毒突变对感染诱导免疫的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c4d/8633007/e7254c49955d/41467_2021_27325_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c4d/8633007/0d935ff04b64/41467_2021_27325_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c4d/8633007/66da4b97c3eb/41467_2021_27325_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c4d/8633007/642fabb5ba56/41467_2021_27325_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c4d/8633007/d6c7941eb501/41467_2021_27325_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c4d/8633007/83610fe0e15e/41467_2021_27325_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c4d/8633007/e7254c49955d/41467_2021_27325_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c4d/8633007/0d935ff04b64/41467_2021_27325_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c4d/8633007/66da4b97c3eb/41467_2021_27325_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c4d/8633007/642fabb5ba56/41467_2021_27325_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c4d/8633007/d6c7941eb501/41467_2021_27325_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c4d/8633007/83610fe0e15e/41467_2021_27325_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c4d/8633007/e7254c49955d/41467_2021_27325_Fig6_HTML.jpg

相似文献

1
Molecular insights into receptor binding energetics and neutralization of SARS-CoV-2 variants.解析受体结合能与中和 SARS-CoV-2 变异株的分子机制
Nat Commun. 2021 Nov 30;12(1):6977. doi: 10.1038/s41467-021-27325-1.
2
Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.常见突变对 SARS-CoV-2 刺突 RBD 及其配体人 ACE2 受体结合亲和力和动力学的影响。
Elife. 2021 Aug 26;10:e70658. doi: 10.7554/eLife.70658.
3
AlphaFold2 Modeling and Molecular Dynamics Simulations of the Conformational Ensembles for the SARS-CoV-2 Spike Omicron JN.1, KP.2 and KP.3 Variants: Mutational Profiling of Binding Energetics Reveals Epistatic Drivers of the ACE2 Affinity and Escape Hotspots of Antibody Resistance.AlphaFold2 对 SARS-CoV-2 刺突奥密克戎 JN.1、KP.2 和 KP.3 变体构象集合的建模和分子动力学模拟:结合能突变分析揭示 ACE2 亲和力的上位驱动因素和抗体耐药性逃逸热点。
Viruses. 2024 Sep 13;16(9):1458. doi: 10.3390/v16091458.
4
Mechanistic insights into the effects of key mutations on SARS-CoV-2 RBD-ACE2 binding.关键突变对 SARS-CoV-2 RBD-ACE2 结合影响的机制见解。
Phys Chem Chem Phys. 2021 Dec 1;23(46):26451-26458. doi: 10.1039/d1cp04005g.
5
Mutations in the SARS-CoV-2 spike receptor binding domain and their delicate balance between ACE2 affinity and antibody evasion.SARS-CoV-2 刺突受体结合域的突变及其在与 ACE2 亲和力和抗体逃逸之间的微妙平衡。
Protein Cell. 2024 May 28;15(6):403-418. doi: 10.1093/procel/pwae007.
6
RBD Double Mutations of SARS-CoV-2 Strains Increase Transmissibility through Enhanced Interaction between RBD and ACE2 Receptor.SARS-CoV-2 株的 RBD 双重突变通过增强 RBD 与 ACE2 受体之间的相互作用增加传染性。
Viruses. 2021 Dec 21;14(1):1. doi: 10.3390/v14010001.
7
Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies.N501Y 型严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)刺突蛋白与血管紧张素转换酶 2(ACE2)及两种强效中和抗体复合物的冷冻电镜结构
PLoS Biol. 2021 Apr 29;19(4):e3001237. doi: 10.1371/journal.pbio.3001237. eCollection 2021 Apr.
8
In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2-Spike RBD Interface.利用计算机模拟方法研究新型英国(B.1.1.7)和南非(501Y.V2)SARS-CoV-2 变异株,重点关注 ACE2-刺突 RBD 界面。
Int J Mol Sci. 2021 Feb 8;22(4):1695. doi: 10.3390/ijms22041695.
9
Possible Link between Higher Transmissibility of Alpha, Kappa and Delta Variants of SARS-CoV-2 and Increased Structural Stability of Its Spike Protein and hACE2 Affinity.可能与 SARS-CoV-2 的 Alpha、Kappa 和 Delta 变体更高的传染性以及其刺突蛋白和 hACE2 亲和力的结构稳定性增加有关。
Int J Mol Sci. 2021 Aug 24;22(17):9131. doi: 10.3390/ijms22179131.
10
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.SARS-CoV-2 变体预测和抗病毒药物设计可通过 RBD 体外进化实现。
Nat Microbiol. 2021 Sep;6(9):1188-1198. doi: 10.1038/s41564-021-00954-4. Epub 2021 Aug 16.

引用本文的文献

1
ACE2 Receptor and Antibody Binding to SARS-CoV‑2 Spikes and Virions by Single-Molecule Fluorescence.通过单分子荧光研究血管紧张素转换酶2受体及抗体与严重急性呼吸综合征冠状病毒2刺突蛋白和病毒粒子的结合情况
ACS Omega. 2025 Jul 31;10(31):34844-34856. doi: 10.1021/acsomega.5c03887. eCollection 2025 Aug 12.
2
Modulation of SARS-CoV-2 spike binding to ACE2 through conformational selection.通过构象选择调节严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白与血管紧张素转换酶2(ACE2)的结合
Nat Nanotechnol. 2025 Jun 10. doi: 10.1038/s41565-025-01908-1.
3
GōMartini 3: From large conformational changes in proteins to environmental bias corrections.

本文引用的文献

1
SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染血液单核细胞以激活NLRP3和AIM2炎性小体、细胞焦亡和细胞因子释放。
Res Sq. 2021 Aug 11:rs.3.rs-153628. doi: 10.21203/rs.3.rs-153628/v1.
2
Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.SARS-CoV-2 天然突变对刺突结构、构象和抗原性的影响。
Science. 2021 Aug 6;373(6555). doi: 10.1126/science.abi6226. Epub 2021 Jun 24.
3
SARS-CoV-2 Variants and Vaccines.
《戈·马蒂尼3:从蛋白质的大构象变化到环境偏差校正》
Nat Commun. 2025 Apr 30;16(1):4051. doi: 10.1038/s41467-025-58719-0.
4
Conformational and Stability Analysis of SARS-CoV-2 Spike Protein Variants by Molecular Simulation.通过分子模拟对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白变体进行构象和稳定性分析。
Pathogens. 2025 Mar 12;14(3):274. doi: 10.3390/pathogens14030274.
5
Variant-Specific Interactions at the Plasma Membrane: Heparan Sulfate's Impact on SARS-CoV-2 Binding Kinetics.质膜上的变体特异性相互作用:硫酸乙酰肝素对SARS-CoV-2结合动力学的影响。
Anal Chem. 2025 Mar 4;97(8):4318-4328. doi: 10.1021/acs.analchem.4c04283. Epub 2025 Feb 20.
6
Probing living cell dynamics and molecular interactions using atomic force microscopy.使用原子力显微镜探究活细胞动力学和分子相互作用。
Biophys Rev. 2024 Dec 28;16(6):663-677. doi: 10.1007/s12551-024-01258-7. eCollection 2024 Dec.
7
From viral assembly to host interaction: AFM's contributions to virology.从病毒组装到宿主相互作用:原子力显微镜对病毒学的贡献。
J Virol. 2025 Jan 31;99(1):e0087324. doi: 10.1128/jvi.00873-24. Epub 2024 Dec 10.
8
Widespread exposure to SARS-CoV-2 in wildlife communities.野生动物群体中广泛存在 SARS-CoV-2 暴露。
Nat Commun. 2024 Jul 29;15(1):6210. doi: 10.1038/s41467-024-49891-w.
9
Micro-second time-resolved X-ray single-molecule internal motions of SARS-CoV-2 spike variants.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白变体的微秒级时间分辨X射线单分子内部运动
Biochem Biophys Rep. 2024 Apr 29;38:101712. doi: 10.1016/j.bbrep.2024.101712. eCollection 2024 Jul.
10
Single-Molecule Investigation of the Binding Interface Stability of SARS-CoV-2 Variants with ACE2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体与血管紧张素转换酶2(ACE2)结合界面稳定性的单分子研究
ACS Nanosci Au. 2024 Mar 8;4(2):136-145. doi: 10.1021/acsnanoscienceau.3c00060. eCollection 2024 Apr 17.
SARS-CoV-2 变异株与疫苗。
N Engl J Med. 2021 Jul 8;385(2):179-186. doi: 10.1056/NEJMsr2105280. Epub 2021 Jun 23.
4
COVID-19 and the intensive care unit: vaccines to the rescue.新冠疫情与重症监护病房:疫苗来救援
Intensive Care Med. 2021 Jul;47(7):786-789. doi: 10.1007/s00134-021-06414-1. Epub 2021 May 25.
5
SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的B.1.1.7和B.1.351刺突变异体与人类血管紧张素转换酶2(ACE2)的结合亲和力增强。
Lancet Infect Dis. 2021 Aug;21(8):1070. doi: 10.1016/S1473-3099(21)00262-0. Epub 2021 May 19.
6
Antibodies and Vaccines Target RBD of SARS-CoV-2.抗体和疫苗靶向严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的受体结合域(RBD)。
Front Mol Biosci. 2021 Apr 22;8:671633. doi: 10.3389/fmolb.2021.671633. eCollection 2021.
7
Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies.N501Y 型严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)刺突蛋白与血管紧张素转换酶 2(ACE2)及两种强效中和抗体复合物的冷冻电镜结构
PLoS Biol. 2021 Apr 29;19(4):e3001237. doi: 10.1371/journal.pbio.3001237. eCollection 2021 Apr.
8
Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike.人血管紧张素转换酶 2 糖基化在与 SARS-CoV-2 刺突结合中的双重性质。
Proc Natl Acad Sci U S A. 2021 May 11;118(19). doi: 10.1073/pnas.2100425118.
9
Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment.SARS-CoV-2 抗体的综合概述及其在 COVID-19 预防和治疗中的可能应用。
Microb Cell Fact. 2021 Apr 22;20(1):88. doi: 10.1186/s12934-021-01576-5.
10
Neutralizing monoclonal antibodies for treatment of COVID-19.用于治疗 COVID-19 的中和单克隆抗体。
Nat Rev Immunol. 2021 Jun;21(6):382-393. doi: 10.1038/s41577-021-00542-x. Epub 2021 Apr 19.